Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
NCT ID: NCT06063044
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
407 participants
OBSERVATIONAL
2018-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder
NCT05442658
Comparative Study of Specific IgE Levels to Common Foods and Aeroallergens Measured by EUROIMMUN Allergy and ImmunoCap
NCT02328170
Non-Immunoglobulin E-mediated Food Allergies in Children
NCT04462978
Epidemiological Investigation and Cohort Study on Food Allergy in Children Aged 3 to 6 Years in Wenzhou and Taizhou Urban Areas
NCT03974555
Immune-supportive Diet and Gut Permeability in Allergic Children
NCT05667610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Respiratory system group
the patients who diagnosed as rhinitis, asthma and conjunctivitis were assigned to the respiratory system group
No interventions assigned to this group
Skin system group
the patients who diagnosed as urticaria and atopic dermatitis were assigned to the skin system group
No interventions assigned to this group
Multiple systems group
the patients who diagnosed with a combination of symptoms from different systems were assigned to the multiple systems group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of asthma.
* Clinical diagnosis of conjunctivitis.
* Clinical diagnosis of urticaria.
* Clinical diagnosis of atopic dermatitis.
* Total IgE,FS-IgE, HDM-IgE and FS-IgG4 must be tested.
Exclusion Criteria
8 Months
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huiying Wang
Role: STUDY_CHAIR
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital,School of Medicine,Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No. 2022-0380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.